Carcinoma of unknown primary site

Free article

Editorial

F A Greco et al. Ann Oncol. 1990.

Free article

. 1990;1(2):98-9.

doi: 10.1093/oxfordjournals.annonc.a057702.

No abstract available

Similar articles

Management of carcinoma of unknown primary site (CUP), any changes?
Hansen HH, Daugaard G. Hansen HH, et al. Ann Oncol. 2001 Apr;12(4):431-2. doi: 10.1023/a:1011192414615. Ann Oncol. 2001. PMID: 11398871 No abstract available.
Poorly differentiated carcinoma or adenocarcinoma of unknown primary site: long-term results with cisplatin-based chemotherapy.
Greco FA, Hainsworth JD. Greco FA, et al. Semin Oncol. 1994 Oct;21(5 Suppl 12):77-82. Semin Oncol. 1994. PMID: 7992071 Review.
[Cytostatic treatment of metastatic adenocarcinoma and anaplastic carcinoma of unknown primary origin].
Aabo K, Rørth M, Hansen HH. Aabo K, et al. Ugeskr Laeger. 1987 Jan 5;149(2):80-1. Ugeskr Laeger. 1987. PMID: 3810973 Danish. No abstract available.
[The chemotherapy of metastases of unknown origin].
Shparyk IaV, Bilyns'kyĭ VT. Shparyk IaV, et al. Lik Sprava. 1996 Jan-Feb;(1-2):45-52. Lik Sprava. 1996. PMID: 9005104 Review. Ukrainian. No abstract available.
Poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown origin: favorable subsets of patients with unknown-primary carcinoma?
Lenzi R, Hess KR, Abbruzzese MC, Raber MN, Ordoñez NG, Abbruzzese JL. Lenzi R, et al. J Clin Oncol. 1997 May;15(5):2056-66. doi: 10.1200/JCO.1997.15.5.2056. J Clin Oncol. 1997. PMID: 9164218

The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primary.
van der Gaast A, Verwij J, Planting AS, Stoter G, Henzen-Logmans SC. van der Gaast A, et al. J Cancer Res Clin Oncol. 1996;122(3):181-85. doi: 10.1007/BF01366960. J Cancer Res Clin Oncol. 1996. PMID: 8601568 Free PMC article.